Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 89 entries
Sorted by: Best Match Show Resources per page
Quasi-Local Energy-Momentum and Angular Momentum in General Relativity.

Living reviews in relativity

Szabados LB.
PMID: 28179826
Living Rev Relativ. 2009;12(1):4. doi: 10.12942/lrr-2009-4. Epub 2009 Jun 19.

The present status of the quasi-local mass, energy-momentum and angular-momentum constructions in general relativity is reviewed. First, the general ideas, concepts, and strategies, as well as the necessary tools to construct and analyze the quasi-local quantities, are recalled. Then,...

Cite
Szabados LB. Quasi-Local Energy-Momentum and Angular Momentum in General Relativity. Living Rev Relativ. 2009;12(1):4doi: 10.12942/lrr-2009-4.
Szabados, L. B. (2009). Quasi-Local Energy-Momentum and Angular Momentum in General Relativity. Living reviews in relativity, 12(1), 4. https://doi.org/10.12942/lrr-2009-4
Szabados, László B. "Quasi-Local Energy-Momentum and Angular Momentum in General Relativity." Living reviews in relativity vol. 12,1 (2009): 4. doi: https://doi.org/10.12942/lrr-2009-4
Szabados LB. Quasi-Local Energy-Momentum and Angular Momentum in General Relativity. Living Rev Relativ. 2009;12(1):4. doi: 10.12942/lrr-2009-4. Epub 2009 Jun 19. PMID: 28179826; PMCID: PMC5256466.
Copy Download .nbib Format: NLM
PlantSize Offers an Affordable, Non-destructive Method to Measure Plant Size and Color .

Frontiers in plant science

Faragó D, Sass L, Valkai I, Andrási N, Szabados L.
PMID: 29520290
Front Plant Sci. 2018 Feb 22;9:219. doi: 10.3389/fpls.2018.00219. eCollection 2018.

Plant size, shape and color are important parameters of plants, which have traditionally been measured by destructive and time-consuming methods. Non-destructive image analysis is an increasingly popular technology to characterize plant development in time. High throughput automatic phenotyping platforms...

Cite
Faragó D, Sass L, Valkai I, et al. PlantSize Offers an Affordable, Non-destructive Method to Measure Plant Size and Color . Front Plant Sci. 2018;9:219doi: 10.3389/fpls.2018.00219.
Faragó, D., Sass, L., Valkai, I., Andrási, N., & Szabados, L. (2018). PlantSize Offers an Affordable, Non-destructive Method to Measure Plant Size and Color . Frontiers in plant science, 9219. https://doi.org/10.3389/fpls.2018.00219
Faragó, Dóra, et al. "PlantSize Offers an Affordable, Non-destructive Method to Measure Plant Size and Color ." Frontiers in plant science vol. 9 (2018): 219. doi: https://doi.org/10.3389/fpls.2018.00219
Faragó D, Sass L, Valkai I, Andrási N, Szabados L. PlantSize Offers an Affordable, Non-destructive Method to Measure Plant Size and Color . Front Plant Sci. 2018 Feb 22;9:219. doi: 10.3389/fpls.2018.00219. eCollection 2018. PMID: 29520290; PMCID: PMC5827667.
Copy Download .nbib Format: NLM
Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report.

Case reports in oncology

Omri HE, Hascsi Z, Taha R, Szabados L, Sabah HE, Gamiel A, Hijji IA.
PMID: 26078742
Case Rep Oncol. 2015 May 07;8(2):226-32. doi: 10.1159/000430768. eCollection 2015.

Tuberculosis (TB) can present with various forms and can occasionally be mistaken for malignancy. Hereby, we report a 53-year-old man diagnosed and treated for Burkitt's lymphoma in 2009 who achieved a complete remission confirmed by a computed tomography (CT)...

Cite
Omri HE, Hascsi Z, Taha R, et al. Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report. Case Rep Oncol. 2015;8(2):226-32doi: 10.1159/000430768.
Omri, H. E., Hascsi, Z., Taha, R., Szabados, L., Sabah, H. E., Gamiel, A., & Hijji, I. A. (2015). Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report. Case reports in oncology, 8(2), 226-32. https://doi.org/10.1159/000430768
Omri, Halima El, et al. "Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report." Case reports in oncology vol. 8,2 (2015): 226-32. doi: https://doi.org/10.1159/000430768
Omri HE, Hascsi Z, Taha R, Szabados L, Sabah HE, Gamiel A, Hijji IA. Tubercular Meningitis and Lymphadenitis Mimicking a Relapse of Burkitt's Lymphoma on (18)F-FDG-PET/CT: A Case Report. Case Rep Oncol. 2015 May 07;8(2):226-32. doi: 10.1159/000430768. eCollection 2015. PMID: 26078742; PMCID: PMC4464102.
Copy Download .nbib Format: NLM
Total Synthesis of Garcifuran B.

The Journal of organic chemistry

Kelly TR, Szabados A, Lee YJ.
PMID: 11671421
J Org Chem. 1997 Jan 24;62(2):428-429. doi: 10.1021/jo9615662.

No abstract available.

Cite
Kelly TR, Szabados A, Lee YJ. Total Synthesis of Garcifuran B. J Org Chem. 1997;62(2):428-429doi: 10.1021/jo9615662.
Kelly, T. R., Szabados, A., & Lee, Y. J. (1997). Total Synthesis of Garcifuran B. The Journal of organic chemistry, 62(2), 428-429. https://doi.org/10.1021/jo9615662
Kelly, T. Ross, et al. "Total Synthesis of Garcifuran B." The Journal of organic chemistry vol. 62,2 (1997): 428-429. doi: https://doi.org/10.1021/jo9615662
Kelly TR, Szabados A, Lee YJ. Total Synthesis of Garcifuran B. J Org Chem. 1997 Jan 24;62(2):428-429. doi: 10.1021/jo9615662. PMID: 11671421.
Copy Download .nbib Format: NLM
Idempotency-conserving iteration scheme for the one-electron density matrix.

Physical review letters

Kohalmi D, Szabados A, Surján PR.
PMID: 16090611
Phys Rev Lett. 2005 Jul 01;95(1):013002. doi: 10.1103/PhysRevLett.95.013002. Epub 2005 Jul 01.

For the first order density matrix P of a noninteracting N-electron problem, an iterative formula is presented that preserves the trace and idempotency of P so that no purification is needed. Hermiticity--which may be slightly violated in the course...

Cite
Kohalmi D, Szabados A, Surján PR. Idempotency-conserving iteration scheme for the one-electron density matrix. Phys Rev Lett. 2005;95(1):013002doi: 10.1103/PhysRevLett.95.013002.
Kohalmi, D., Szabados, A., & Surján, P. R. (2005). Idempotency-conserving iteration scheme for the one-electron density matrix. Physical review letters, 95(1), 013002. https://doi.org/10.1103/PhysRevLett.95.013002
Kohalmi, Dóra, et al. "Idempotency-conserving iteration scheme for the one-electron density matrix." Physical review letters vol. 95,1 (2005): 013002. doi: https://doi.org/10.1103/PhysRevLett.95.013002
Kohalmi D, Szabados A, Surján PR. Idempotency-conserving iteration scheme for the one-electron density matrix. Phys Rev Lett. 2005 Jul 01;95(1):013002. doi: 10.1103/PhysRevLett.95.013002. Epub 2005 Jul 01. PMID: 16090611.
Copy Download .nbib Format: NLM
[Familial polycystic affections].

Magyar sebeszet

SZABADOS J.
PMID: 15416219
Magy Seb. 1949;2(3):63-6.

No abstract available.

Cite
SZABADOS J. Polycystás vesemegbetegedések halmozódása egy családban. [Familial polycystic affections]. Magy Seb. 1949;2(3):63-6
SZABADOS, J. (1949). Polycystás vesemegbetegedések halmozódása egy családban. [Familial polycystic affections]. Magyar sebeszet, 2(3), 63-6.
SZABADOS, J. "Polycystás vesemegbetegedések halmozódása egy családban." [Familial polycystic affections]. Magyar sebeszet vol. 2,3 (1949): 63-6.
SZABADOS J. Polycystás vesemegbetegedések halmozódása egy családban. [Familial polycystic affections]. Magy Seb. 1949;2(3):63-6. Undetermined. PMID: 15416219.
Copy Download .nbib Format: NLM
IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature.

International journal of surgery case reports

Sulieman I, Mahfouz A, AlKuwari E, Szabados L, Elmoghazy W, Elaffandi A, Khalaf H.
PMID: 30096533
Int J Surg Case Rep. 2018;50:100-105. doi: 10.1016/j.ijscr.2018.07.030. Epub 2018 Jul 31.

INTRODUCTION: Most patients with pancreatic masses pose a diagnostic challenge when a benign lesion is suspected, and often, resection is needed before a benign diagnosis is confirmed.PRESENTATION OF CASE: A 57 years old male patient presented with a pancreatic...

Cite
Sulieman I, Mahfouz A, AlKuwari E, et al. IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature. Int J Surg Case Rep. 2018;50:100-105doi: 10.1016/j.ijscr.2018.07.030.
Sulieman, I., Mahfouz, A., AlKuwari, E., Szabados, L., Elmoghazy, W., Elaffandi, A., & Khalaf, H. (2018). IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature. International journal of surgery case reports, 50100-105. https://doi.org/10.1016/j.ijscr.2018.07.030
Sulieman, Ibnouf, et al. "IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature." International journal of surgery case reports vol. 50 (2018): 100-105. doi: https://doi.org/10.1016/j.ijscr.2018.07.030
Sulieman I, Mahfouz A, AlKuwari E, Szabados L, Elmoghazy W, Elaffandi A, Khalaf H. IgG4-related disease mimicking pancreatic cancer: Case report and review of the literature. Int J Surg Case Rep. 2018;50:100-105. doi: 10.1016/j.ijscr.2018.07.030. Epub 2018 Jul 31. PMID: 30096533; PMCID: PMC6082998.
Copy Download .nbib Format: NLM
Cytoreductive nephrectomy in the current treatment algorithm.

Therapeutic advances in medical oncology

Kuusk T, Szabados B, Liu WK, Powles T, Bex A.
PMID: 31632471
Ther Adv Med Oncol. 2019 Sep 27;11:1758835919879026. doi: 10.1177/1758835919879026. eCollection 2019.

The two recent prospective randomized trials CARMENA and SURTIME have changed the therapy paradigm of metastatic renal cell carcinoma. The CARMENA trial was conducted to investigate whether cytoreductive nephrectomy (CN) is required in the targeted therapy area, whereas SURTIME...

Cite
Kuusk T, Szabados B, Liu WK, et al. Cytoreductive nephrectomy in the current treatment algorithm. Ther Adv Med Oncol. 2019;11:1758835919879026doi: 10.1177/1758835919879026.
Kuusk, T., Szabados, B., Liu, W. K., Powles, T., & Bex, A. (2019). Cytoreductive nephrectomy in the current treatment algorithm. Therapeutic advances in medical oncology, 111758835919879026. https://doi.org/10.1177/1758835919879026
Kuusk, Teele, et al. "Cytoreductive nephrectomy in the current treatment algorithm." Therapeutic advances in medical oncology vol. 11 (2019): 1758835919879026. doi: https://doi.org/10.1177/1758835919879026
Kuusk T, Szabados B, Liu WK, Powles T, Bex A. Cytoreductive nephrectomy in the current treatment algorithm. Ther Adv Med Oncol. 2019 Sep 27;11:1758835919879026. doi: 10.1177/1758835919879026. eCollection 2019. PMID: 31632471; PMCID: PMC6767741.
Copy Download .nbib Format: NLM
Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition.

European urology oncology

Lam JM, Liu WK, Powles T, Tang YZ, Szabados B.
PMID: 31151926
Eur Urol Oncol. 2021 Aug;4(4):659-662. doi: 10.1016/j.euo.2019.03.001. Epub 2019 Apr 09.

There are few data on outcomes for patients with metastatic urothelial carcinoma (MUC) who receive chemotherapy (CT) after progression on immune checkpoint inhibitors (ICIs). We carried out a retrospective single-centre analysis of MUC patients who progressed after ICI and...

Cite
Lam JM, Liu WK, Powles T, et al. Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition. Eur Urol Oncol. 2019;4(4):659-662doi: 10.1016/j.euo.2019.03.001.
Lam, J. M., Liu, W. K., Powles, T., Tang, Y. Z., & Szabados, B. (2021). Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition. European urology oncology, 4(4), 659-662. https://doi.org/10.1016/j.euo.2019.03.001
Lam, Jie M, et al. "Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition." European urology oncology vol. 4,4 (2021): 659-662. doi: https://doi.org/10.1016/j.euo.2019.03.001
Lam JM, Liu WK, Powles T, Tang YZ, Szabados B. Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition. Eur Urol Oncol. 2021 Aug;4(4):659-662. doi: 10.1016/j.euo.2019.03.001. Epub 2019 Apr 09. PMID: 31151926.
Copy Download .nbib Format: NLM
Frequency comb up- and down-conversion in synchronously driven χ.

Optics letters

Herr SJ, Brasch V, Szabados J, Obrzud E, Jia Y, Lecomte S, Buse K, Breunig I, Herr T.
PMID: 30499983
Opt Lett. 2018 Dec 01;43(23):5745-5748. doi: 10.1364/OL.43.005745.

Optical frequency combs are key to optical precision measurements. While most frequency combs operate in the near-infrared (NIR) regime, many applications require combs at mid-infrared (MIR), visible (VIS), or even ultra-violet (UV) wavelengths. Frequency combs can be transferred to...

Cite
Herr SJ, Brasch V, Szabados J, et al. Frequency comb up- and down-conversion in synchronously driven χ. Opt Lett. 2018;43(23):5745-5748doi: 10.1364/OL.43.005745.
Herr, S. J., Brasch, V., Szabados, J., Obrzud, E., Jia, Y., Lecomte, S., Buse, K., Breunig, I., & Herr, T. (2018). Frequency comb up- and down-conversion in synchronously driven χ. Optics letters, 43(23), 5745-5748. https://doi.org/10.1364/OL.43.005745
Herr, Simon J, et al. "Frequency comb up- and down-conversion in synchronously driven χ." Optics letters vol. 43,23 (2018): 5745-5748. doi: https://doi.org/10.1364/OL.43.005745
Herr SJ, Brasch V, Szabados J, Obrzud E, Jia Y, Lecomte S, Buse K, Breunig I, Herr T. Frequency comb up- and down-conversion in synchronously driven χ. Opt Lett. 2018 Dec 01;43(23):5745-5748. doi: 10.1364/OL.43.005745. PMID: 30499983.
Copy Download .nbib Format: NLM
Corrigendum to: The mitogen-activated protein kinase 4-phosphorylated heat shock factor A4A regulates responses to combined salt and heat stresses.

Journal of experimental botany

Andrási N, Rigó G, Zsigmond L, Pérez-Salamó I, Papdi C, Klement E, Pettkó-Szandtner A, Baba AI, Ayaydin F, Dasari R, Cséplő Á, Szabados L.
PMID: 34180987
J Exp Bot. 2021 Jul 28;72(15):5781. doi: 10.1093/jxb/eraa552.

No abstract available.

Cite
Andrási N, Rigó G, Zsigmond L, et al. Corrigendum to: The mitogen-activated protein kinase 4-phosphorylated heat shock factor A4A regulates responses to combined salt and heat stresses. J Exp Bot. 2021;72(15):5781doi: 10.1093/jxb/eraa552.
Andrási, N., Rigó, G., Zsigmond, L., Pérez-Salamó, I., Papdi, C., Klement, E., Pettkó-Szandtner, A., Baba, A. I., Ayaydin, F., Dasari, R., Cséplő, �. �., & Szabados, L. (2021). Corrigendum to: The mitogen-activated protein kinase 4-phosphorylated heat shock factor A4A regulates responses to combined salt and heat stresses. Journal of experimental botany, 72(15), 5781. https://doi.org/10.1093/jxb/eraa552
Andrási, Norbert, et al. "Corrigendum to: The mitogen-activated protein kinase 4-phosphorylated heat shock factor A4A regulates responses to combined salt and heat stresses." Journal of experimental botany vol. 72,15 (2021): 5781. doi: https://doi.org/10.1093/jxb/eraa552
Andrási N, Rigó G, Zsigmond L, Pérez-Salamó I, Papdi C, Klement E, Pettkó-Szandtner A, Baba AI, Ayaydin F, Dasari R, Cséplő Á, Szabados L. Corrigendum to: The mitogen-activated protein kinase 4-phosphorylated heat shock factor A4A regulates responses to combined salt and heat stresses. J Exp Bot. 2021 Jul 28;72(15):5781. doi: 10.1093/jxb/eraa552. PMID: 34180987; PMCID: PMC8318257.
Copy Download .nbib Format: NLM
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment.

European urology open science

Meerveld-Eggink A, Graafland N, Wilgenhof S, Van Thienen JV, Lalezari F, Grant M, Szabados B, Abu-Ghanem Y, Kuusk T, Boleti E, Blank CU, Haanen JBAG, Powles T, Bex A.
PMID: 35024632
Eur Urol Open Sci. 2022 Jan 03;35:54-58. doi: 10.1016/j.euros.2021.11.003. eCollection 2022 Jan.

Following CARMENA and SURTIME, patients with metastatic renal cell carcinoma (mRCC) and International Metastatic RCC Database Consortium (IMDC) intermediate and poor risk receive systemic therapy with the primary tumour (primary) in place, with the option of deferred cytoreductive nephrectomy...

Cite
Meerveld-Eggink A, Graafland N, Wilgenhof S, et al. Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment. Eur Urol Open Sci. 2022;35:54-58doi: 10.1016/j.euros.2021.11.003.
Meerveld-Eggink, A., Graafland, N., Wilgenhof, S., Van Thienen, J. V., Lalezari, F., Grant, M., Szabados, B., Abu-Ghanem, Y., Kuusk, T., Boleti, E., Blank, C. U., Haanen, J. B. A. G., Powles, T., & Bex, A. (2022). Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment. European urology open science, 3554-58. https://doi.org/10.1016/j.euros.2021.11.003
Meerveld-Eggink, Aafke, et al. "Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment." European urology open science vol. 35 (2022): 54-58. doi: https://doi.org/10.1016/j.euros.2021.11.003
Meerveld-Eggink A, Graafland N, Wilgenhof S, Van Thienen JV, Lalezari F, Grant M, Szabados B, Abu-Ghanem Y, Kuusk T, Boleti E, Blank CU, Haanen JBAG, Powles T, Bex A. Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment. Eur Urol Open Sci. 2022 Jan 03;35:54-58. doi: 10.1016/j.euros.2021.11.003. eCollection 2022 Jan. PMID: 35024632; PMCID: PMC8738899.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 89 entries